Researchers at JCOIN’s Brown University Clinical Research Center (MPIs: Rosemarie Martin, PhD, Damaris Rohsenow, PhD), developed the Prescription Drug Abuse Policy System (PDAPS). This online resource provides data and information on state policies and laws aimed at responding to substance use disorders, including topics related to justice-involved populations, naloxone access, medication for opioid use disorder (MOUD), prescription drug monitoring programs, and more.
Dr. Robert Miranda and his lab have launched a brand new website to highlight their work with Vista Clinical Research Group. Faculty and postdoctoral fellows affiliated with the Vista Clinical Research Group — including scientists from Brown University, Bradley Hospital, Lifespan Health System, and beyond — share a passion for advancing knowledge and clinical care for people who struggle with addiction.
CAAS Senior Research Assistant Jake Tempchin will matriculate this fall at the University of Memphis in pursuit of a PhD in clinical psychology. He will study with Dr. Jim Murphy, focusing on behavioral economics, motivational interviewing, and the implementation of interventions to reduce harms experienced from substance use.
Dr. David Zelaya recently published "Psychometric validation and extension of the LGBT people of Color Microaggressions Scale with a sample of sexual minority BIPOC college students" in the journal Psychology of Sexual Orientation and Gender Diversity. Dr. Zelaya's research provides further rigorous statistical support and evidence for researchers and clinicians to use the LGBT People of Color Microaggressions Scale.
Dr. Matthew Meisel had a paper accepted for publication in the journal BMC Psychology. In the manuscript, in a sample of emerging adults who never attended 4-year college, the authors found that most of the sample experienced some form of education-based stigma and discrimination and that these experiences were associated with worse mental health symptoms.
